Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

DFS Furniture FY profits seen 'slightly above' guidance

(Sharecast News) - Retailer DFS Furniture said on Thursday that FY profits were expected to be "slightly above" the top end of guidance on the back of "strong trading and good cost control". DFS said FY profits were expected to be above guidance of £25.0m to £29.0m and up roughly £20.0m year-on-year, driven by solid trading, gross margin rate progression and continued cost discipline.

The London-listed group also said its strong trading performance had continued in H2, with group order intake up 10% year-on-year, demonstrating "significant outperformance" of a market that "remains subdued".

DFS said both of its retail brands "performed well", with DFS up 8.7% and Sofology up 16.2% year-on-year due to the successful implementation of growth initiatives.

Gross sales were up 5.8% year-on-year, lower than the level recorded in FY24 due to a shift in customer orders to ranges with longer lead times and the impact of the prior year being a 53-week financial reporting period.

Chief executive Tim Stacey said: "We are pleased to report that we expect profit for the full year to be slightly above the top end of our guidance. Our excellent first half performance set the foundation for our success, with strong trading through the rest of the year with both our DFS and Sofology brands outperforming the market.

"Looking forward, we are confident that the Group is well positioned to drive attractive returns for shareholders as the market recovers and we remain focused on delivering our medium-term ambition of £1.4bn revenue and 8% PBT margins."

As of 1005 BST, DFS shares were up 5.14% at 173.48p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.